| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, AND ICOSAPENT | 1 | 0.1667 |
| 1 | ELAGOLIX AND ESTRADIOL AND NORETHISTERONE | 34 | 0.0567 |
| 2 | COPPER | 1993 | 0.0462 |
| 3 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 4 | RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE | 16 | 0.0106 |
| 5 | BULEVIRTIDE | 1 | 0.0104 |
| 6 | ALUMINUM CHLORIDE | 1 | 0.0066 |
| 7 | LEVONORGESTREL/ETHINYL ESTRADIOL | 6 | 0.0055 |
| 8 | ELAGOLIX | 20 | 0.0054 |
| 9 | SARECYCLINE HYDROCHLORIDE | 1 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 1993 |
| 1 | Progestin [EPC] | 313 |
| 2 | Progestin-containing Intrauterine System [EPC] | 234 |
| 3 | Benzodiazepine [EPC] | 54 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 53 |
| 5 | Estrogen [EPC] | 46 |
| 6 | Aldosterone Antagonist [EPC] | 40 |
| 7 | GLP-1 Receptor Agonist [EPC] | 35 |
| 8 | Provitamin D2 Compound [EPC] | 32 |
| 9 | Corticosteroid [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 1993 | 0.0403 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | alpha-Hydroxy Acid [EPC] | 3 | 0.0014 |
| 3 | Thyroid Hormone Receptor beta Agonist [EPC] | 3 | 0.0013 |
| 4 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |
| 5 | Progestin [EPC] | 313 | 0.0011 |
| 6 | Progesterone [EPC] | 22 | 0.0009 |
| 7 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 8 | Antifibrinolytic Agent [EPC] | 9 | 0.0009 |
| 9 | Leptin Analog [EPC] | 1 | 0.0008 |